CRBU

Caribou Biosciences, Inc. $0.44 as of 2026-11-02
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.1%
Next 1 week
-0.6%
Next 1 month
+4.9%
Seasonality
Not enough history
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 45
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is -0.45%/day.
Mean-reversion stats →
1-month breakdown — Market · β 2.12 +5.0% · Seasonal tilt (4y) -0.1%
$3M/day volume 84% volatility -81% 1-year
52-week range · 1% of the way up · -88% from the high
$0.41$3.54

Earnings Full history →

Next report 2026-11-11 (Wednesday, after close, in 8 days) · EPS est. -0.26.

1-day std dev
9.6%
Finished up
52%
Biggest pop
+14.3%
Biggest drop
-30.5%

Standard deviation of the close-to-close move over the last 21 reports. History, not a forecast.

ReportedEst.Actual SurpriseGap Day 1Day 5
2026-08-13 beat -0.31 -0.24 +21.7% +0.0% -1.9% +3.1%
2026-05-07 beat -0.31 -0.26 +16.1% +1.1% +3.2% +13.8%
2026-03-05 beat -0.32 -0.28 +12.9% -2.9% +6.4% +9.9%
2025-11-12 beat -0.36 -0.30 +15.9% +1.8% -12.2% -22.6%
2025-08-12 beat -0.42 -0.35 +16.7% -3.9% +8.9% +0.6%
2025-05-08 beat -0.44 -0.44 +2.2% +0.0% -2.0% +18.7%
2025-03-10 beat -0.40 -0.39 +3.3% +1.4% -3.2% -14.0%
2024-11-06 beat -0.45 -0.38 +15.1% -3.6% +1.1% -24.0%
2024-08-06 beat -0.44 -0.44 +0.9% +3.8% -2.8% -2.8%
2024-05-07 miss -0.38 -0.47 -21.3% -2.4% -6.2% -2.4%
2024-03-11 miss -0.35 -0.41 -15.5% -0.8% -30.5% -25.3%
2023-11-07 beat -0.36 -0.12 +67.3% +4.4% -5.0% -2.1%
2023-08-08 miss -0.48 -0.49 -1.1% +2.3% +5.8% -1.7%
2023-05-09 beat -0.49 -0.46 +5.7% +2.3% +6.8% -0.2%
2023-03-09 beat -0.47 -0.46 +1.2% +0.5% -6.0% -10.0%
2022-11-08 beat -0.48 -0.44 +8.9% +1.9% +0.8% -1.4%
2022-08-09 miss -0.36 -0.44 -21.1% -0.4% +14.3% +27.9%
2022-05-09 beat -0.34 -0.32 +7.2% +4.9% +9.3% +45.0%
2022-03-21 beat -0.34 -0.31 +8.8% +2.1% +9.5% +3.3%
2021-11-09 miss -0.24 -0.40 -68.8% +0.4% -1.9% +5.2%
2021-09-02 miss 0.47 -1.55 -427.6% +1.1% +5.2% -3.1%

Not investment advice.